Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

1.

Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.

Kim RY, Hoffman AS, Itoh N, Ao Y, Spence R, Sofroniew MV, Voskuhl RR.

J Neuroimmunol. 2014 Jun 24. pii: S0165-5728(14)00180-5. doi: 10.1016/j.jneuroim.2014.06.009. [Epub ahead of print]

PMID:
25005117
[PubMed - as supplied by publisher]
2.

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Kurth F, Luders E, Sicotte NL, Gaser C, Giesser BS, Swerdloff RS, Montag MJ, Voskuhl RR, Mackenzie-Graham A.

Neuroimage Clin. 2014 Mar 6;4:454-60. doi: 10.1016/j.nicl.2014.03.001. eCollection 2014.

PMID:
24634831
[PubMed]
Free PMC Article
3.

XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.

Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR.

Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2806-11. doi: 10.1073/pnas.1307091111. Epub 2014 Feb 3.

PMID:
24550311
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons.

Spence RD, Wisdom AJ, Cao Y, Hill HM, Mongerson CR, Stapornkul B, Itoh N, Sofroniew MV, Voskuhl RR.

J Neurosci. 2013 Jun 26;33(26):10924-33. doi: 10.1523/JNEUROSCI.0886-13.2013.

PMID:
23804112
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.

Wisdom AJ, Cao Y, Itoh N, Spence RD, Voskuhl RR.

J Neurosci Res. 2013 Jul;91(7):901-8. doi: 10.1002/jnr.23219. Epub 2013 Apr 30.

PMID:
23633287
[PubMed - indexed for MEDLINE]
6.

Assisted reproduction technology in multiple sclerosis: giving birth to a new avenue of research in hormones and autoimmunity.

Voskuhl RR.

Ann Neurol. 2012 Nov;72(5):631-2. doi: 10.1002/ana.23779. No abstract available.

PMID:
23280787
[PubMed - indexed for MEDLINE]
7.

Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease.

Ziehn MO, Avedisian AA, Dervin SM, Umeda EA, O'Dell TJ, Voskuhl RR.

J Neurosci. 2012 Sep 5;32(36):12312-24. doi: 10.1523/JNEUROSCI.2796-12.2012.

PMID:
22956822
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation.

Gold SM, Sasidhar MV, Lagishetty V, Spence RD, Umeda E, Ziehn MO, Krieger T, Schulz KH, Heesen C, Hewison M, Voskuhl RR.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1402-10. doi: 10.1210/jc.2012-1294. Epub 2012 Jun 1.

PMID:
22659246
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The XX sex chromosome complement in mice is associated with increased spontaneous lupus compared with XY.

Sasidhar MV, Itoh N, Gold SM, Lawson GW, Voskuhl RR.

Ann Rheum Dis. 2012 Aug;71(8):1418-22. doi: 10.1136/annrheumdis-2011-201246. Epub 2012 May 12.

PMID:
22580585
[PubMed - indexed for MEDLINE]
10.

Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.

Ziehn MO, Avedisian AA, Dervin SM, O'Dell TJ, Voskuhl RR.

Lab Invest. 2012 Aug;92(8):1234-45. doi: 10.1038/labinvest.2012.76. Epub 2012 Apr 23.

PMID:
22525427
[PubMed - indexed for MEDLINE]
Free Article
11.

Sex-related factors in multiple sclerosis susceptibility and progression.

Voskuhl RR, Gold SM.

Nat Rev Neurol. 2012 Mar 27;8(5):255-63. doi: 10.1038/nrneurol.2012.43. Review.

PMID:
22450508
[PubMed - indexed for MEDLINE]
12.

Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.

MacKenzie-Graham AJ, Rinek GA, Avedisian A, Morales LB, Umeda E, Boulat B, Jacobs RE, Toga AW, Voskuhl RR.

J Neurosci Res. 2012 Jul;90(7):1310-23. doi: 10.1002/jnr.23019. Epub 2012 Mar 13.

PMID:
22411609
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Pregnancy: a "modifiable" risk factor in MS?

Daumer M, Weinshenker BG, Voskuhl R.

Neurology. 2012 Mar 20;78(12):846-8. doi: 10.1212/WNL.0b013e31824d1858. Epub 2012 Mar 7. No abstract available.

PMID:
22402865
[PubMed - indexed for MEDLINE]
14.

Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Spence RD, Voskuhl RR.

Front Neuroendocrinol. 2012 Jan;33(1):105-15. doi: 10.1016/j.yfrne.2011.12.001. Epub 2011 Dec 24. Review.

PMID:
22209870
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

MacKenzie-Graham A, Rinek GA, Avedisian A, Gold SM, Frew AJ, Aguilar C, Lin DR, Umeda E, Voskuhl RR, Alger JR.

Neuroimage. 2012 Mar;60(1):95-104. doi: 10.1016/j.neuroimage.2011.11.099. Epub 2011 Dec 13.

PMID:
22182769
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Neuroprotection mediated through estrogen receptor-alpha in astrocytes.

Spence RD, Hamby ME, Umeda E, Itoh N, Du S, Wisdom AJ, Cao Y, Bondar G, Lam J, Ao Y, Sandoval F, Suriany S, Sofroniew MV, Voskuhl RR.

Proc Natl Acad Sci U S A. 2011 May 24;108(21):8867-72. doi: 10.1073/pnas.1103833108. Epub 2011 May 9.

PMID:
21555578
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sex differences in autoimmune diseases.

Voskuhl R.

Biol Sex Differ. 2011 Jan 4;2(1):1. doi: 10.1186/2042-6410-2-1.

PMID:
21208397
[PubMed]
Free PMC Article
18.

Estrogen receptor-β ligand treatment modulates dendritic cells in the target organ during autoimmune demyelinating disease.

Du S, Sandoval F, Trinh P, Umeda E, Voskuhl R.

Eur J Immunol. 2011 Jan;41(1):140-50. doi: 10.1002/eji.201040796. Epub 2010 Dec 9.

PMID:
21182085
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

An animal model of cortical and callosal pathology in multiple sclerosis.

Mangiardi M, Crawford DK, Xia X, Du S, Simon-Freeman R, Voskuhl RR, Tiwari-Woodruff SK.

Brain Pathol. 2011 May;21(3):263-78. doi: 10.1111/j.1750-3639.2010.00444.x. Epub 2010 Nov 10.

PMID:
21029240
[PubMed - indexed for MEDLINE]
20.

Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.

Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, Tiwari-Woodruff SK.

Brain. 2010 Oct;133(10):2999-3016. doi: 10.1093/brain/awq237. Epub 2010 Sep 21.

PMID:
20858739
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk